BIOTECH
Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®
February 8, 2023
Ad hoc announcement pursuant to Art. 53 LR SGI debt facility to provide Spexis up...
